2005, Haje & Naoom 2015, Tsounapi et al
Studies in languages other than English and case reports/case series were not included
"It gives employers and benefits leaders something they have not had until now: proof that with the right wraparound behavioral support, GLP-1 medications can deliver sustained results - year over year - for their populations, including for those high-risk, high cost employees they cannot afford to ignore." 2026 Calibrate Results Report: Key Findings Sustained, four-year weight loss
Usually managed with medications and PCI (angioplasty/stenting) when needed
Someone may be more at risk for yeast infections or other fungal infections
A complete blood cell count was performed on each rabbit prior to anesthesia on Day 0, and again on Days 7 and 14, to monitor for any systemic abnormalities [2]